Howard Weintraub

3.3k total citations · 2 hit papers
73 papers, 1.9k citations indexed

About

Howard Weintraub is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Howard Weintraub has authored 73 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Endocrinology, Diabetes and Metabolism, 25 papers in Cardiology and Cardiovascular Medicine and 24 papers in Surgery. Recurrent topics in Howard Weintraub's work include Lipoproteins and Cardiovascular Health (15 papers), Blood Pressure and Hypertension Studies (15 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers). Howard Weintraub is often cited by papers focused on Lipoproteins and Cardiovascular Health (15 papers), Blood Pressure and Hypertension Studies (15 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers). Howard Weintraub collaborates with scholars based in United States, Switzerland and Australia. Howard Weintraub's co-authors include Arthur Schwartzbard, Milo Gibaldi, Jeffrey S. Berger, Edward A. Fisher, Jonathan Newman, Sripal Bangalore, Ira J. Goldberg, Bora Toklu, Franz H. Messerli and Eugenia Gianos and has published in prestigious journals such as Circulation, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Howard Weintraub

71 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)

2022 167 citations Michael J. Koren, Patrick M. Moriarty et al. profile →
Ten things to know about ten cardiovascular disease risk factors

2021 150 citations Howard Weintraub, Michael D. Shapiro et al. profile →

Peers

Howard Weintraub

SURGE

CCM

EDM

Emma A. Meagher United States

Marcelo Chiara Bertolami Brazil

Zorana Jelić‐Ivanović Serbia

Avishay Elis Israel

Slavica Spasić Serbia

Anna Tavridou Greece

Jean‐Pierre Desager Belgium

Sergio D’Addato Italy

José Pablo Werba Italy

Payal Kohli United States

Emma A. Meagher United States

Howard Weintraub

683 ×1.2

SURGE

322 ×0.6

CCM

393 ×0.8

EDM

278 ×0.9

216 ×1.1

Citations per year, relative to Howard Weintraub Howard Weintraub (= 1×) peers Emma A. Meagher

Countries citing papers authored by Howard Weintraub

Since Specialization

Citations

This map shows the geographic impact of Howard Weintraub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Weintraub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Weintraub more than expected).

Fields of papers citing papers by Howard Weintraub

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard Weintraub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Weintraub. The network helps show where Howard Weintraub may publish in the future.

Co-authorship network of co-authors of Howard Weintraub

This figure shows the co-authorship network connecting the top 25 collaborators of Howard Weintraub. A scholar is included among the top collaborators of Howard Weintraub based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howard Weintraub. Howard Weintraub is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boffa, Michael B., Judy Zhong, Michael Garshick, et al.. (2024). Variation in lipoprotein(a) response to potent lipid lowering: The role of apolipoprotein (a) isoform size. Journal of clinical lipidology. 19(1). 39–50. 1 indexed citations

Shapiro, Michael D., Howard Weintraub, Seth J. Baum, et al.. (2024). Lipoprotein(a) levels in a population with clinical atherosclerotic cardiovascular disease in the United States: A subanalysis from the Lp(a)HERITAGE study. Journal of clinical lipidology. 19(1). 28–38. 2 indexed citations

Garshick, Michael, Kamelia Drenkova, Tessa J. Barrett, et al.. (2021). LIPOPROTEIN(A) IS ELEVATED IN PSORIASIS AND ASSOCIATED WITH CARDIOVASCULAR RISK. Journal of the American College of Cardiology. 77(18). 1580–1580. 1 indexed citations

Koren, Michael J., Patrick M. Moriarty, Joel Neutel, et al.. (2020). Abstract 13951: Safety, Tolerability and Efficacy of Single-dose Amg 890, a Novel Sirna Targeting Lp(a), in Healthy Subjects and Subjects With Elevated Lp(a). Circulation. 142(Suppl_3). 25 indexed citations

Newman, Jonathan, et al.. (2018). The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction. Journal of the American College of Cardiology. 72(15). 1856–1869. 65 indexed citations

Bangalore, Sripal, Bora Toklu, Eugenia Gianos, et al.. (2017). Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials. The American Journal of Medicine. 130(6). 707–719.e8. 109 indexed citations

Newman, Jonathan, Arthur Schwartzbard, Howard Weintraub, Ira J. Goldberg, & Jeffrey S. Berger. (2017). Primary Prevention of Cardiovascular Disease in Diabetes Mellitus. Journal of the American College of Cardiology. 70(7). 883–893. 123 indexed citations

Bangalore, Sripal, Robert J. Fakheri, Bora Toklu, et al.. (2016). Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients Without Heart Failure? Insights From 254,301 Patients From Randomized Trials. Mayo Clinic Proceedings. 91(1). 51–60. 71 indexed citations

Weintraub, Howard, Steven H. Lamm, James Underberg, et al.. (2016). Cardiovascular Effects of the New Weight Loss Agents. Journal of the American College of Cardiology. 68(8). 849–859. 19 indexed citations

10.

Schwartzbard, Arthur, et al.. (2016). Management of Hypogonadism in Cardiovascular Patients. Urologic Clinics of North America. 43(2). 247–260. 3 indexed citations

11.

Newman, Jonathan, Caron Rockman, Mikhail Kosiborod, et al.. (2016). Diabetes mellitus is a coronary heart disease risk equivalent for peripheral vascular disease. American Heart Journal. 184. 114–120. 37 indexed citations

12.

Schwartzbard, Arthur, et al.. (2015). The Role of Testosterone Therapy in Cardiovascular Mortality: Culprit or Innocent Bystander?. Current Atherosclerosis Reports. 17(3). 490–490. 4 indexed citations

13.

Gianos, Eugenia, Yu Guo, Arthur Schwartzbard, et al.. (2014). Suboptimal risk factor control in patients undergoing elective coronary or peripheral percutaneous intervention. American Heart Journal. 168(3). 310–316.e3. 11 indexed citations

14.

Cushman, William C., Daniel Duprez, Howard Weintraub, et al.. (2012). Home and clinic blood pressure responses in elderly individuals with systolic hypertension. Journal of the American Society of Hypertension. 6(3). 210–218. 3 indexed citations

15.

Singh, Amita, Arthur Schwartzbard, Eugenia Gianos, Jeffrey S. Berger, & Howard Weintraub. (2012). What should we do about Hypertriglyceridemia in Coronary Artery Disease Patients?. Current Treatment Options in Cardiovascular Medicine. 15(1). 104–117. 5 indexed citations

16.

Tran, Henry, Arthur Schwartzbard, & Howard Weintraub. (2011). Role of RAAS Inhibition in the Prevention of Cardiovascular Disease. Current Treatment Options in Cardiovascular Medicine. 13(4). 279–288. 6 indexed citations

17.

Izzo, Joseph L., Howard Weintraub, Daniel Duprez, et al.. (2011). Treating Systolic Hypertension in the Very Elderly With Valsartan-Hydrochlorothiazide vs Either Monotherapy: ValVET Primary Results. Journal of Clinical Hypertension. 13(10). 722–730. 10 indexed citations

18.

Weintraub, Howard. (2008). Identifying the Vulnerable Patient with Rupture-Prone Plaque. The American Journal of Cardiology. 101(12). S3–S10. 47 indexed citations

19.

Weintraub, Howard, et al.. (2008). The Pleiotropic Effects of Antihypertensive Agents: Do They Account for Additional Cardiovascular Benefit Beyond BP Reduction?. Southern Medical Journal. 101(8). 818–823. 5 indexed citations

20.

Huang, Shiew‐Mei, Thomas B. Marriott, Howard Weintraub, et al.. (1988). Single-dose and multiple-dose pharmacokinetics of etintidine in healthy volunteers. European Journal of Clinical Pharmacology. 34(1). 101–104. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact